Efficacy and Safety Study of Toremifene Citrate for the Reduction in the Risk of New Bone Fracture Occurrences in Men With Prostate Cancer

Stopped cost of conducting the study and increased burden on the clinical trial professionals make it impossible for us to proceed with the development of the drug.

Conditions

• Risk of Bone Fracture Occurrences

Interventions

• DRUG: Toremifene

Sponsor

GTx

Collaborators

• [object Object]